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Abstract
 
The activation-induced cytidine deaminase (AID) is required for somatic hypermutation
(SHM) and class-switch recombination (CSR) of immunoglobulin (Ig) genes, both of which
are associated with DNA double-strand breaks (DSBs). As AID is capable of deaminating
deoxy-cytidine (dC) to deoxy-uracil (dU), it might induce nicks (single strand DNA breaks)
and also DNA DSBs via a U-DNA glycosylase-mediated base excision repair pathway
(‘DNA-substrate model’). Alternatively, AID functions like its closest homologue Apobec1 as a
catalytic subunit of a RNA editing holoenzyme (‘RNA-substrate model’). Although rearranged
V
 
 
 
 genes are preferred targets of SHM we found that germinal center (GC) B cells of AID-
proficient and -deficient V
 
 
 
1-expressing GC B cells display a similar frequency, distribution,
and sequence preference of DSBs in rearranged and also in germline V
 
 
 
1 genes. The possible
roles of DSBs in relation to AID function and SHM are discussed.
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Introduction
 
Somatic hypermutation (SHM) of B cell Ig variable region
genes contributes to the diversification of the antibody rep-
ertoire. Antigen-activated B cells migrate into B cell folli-
cles of secondary lymphoid tissues, where they undergo
rapid expansion and establish oligoclonal germinal centers
(GCs). The GC is a specialized microenvironment where B
cells receive specific signals enabling them to further diver-
sify their V(D)J rearranged Ig heavy chain (IgHC) and light
chain (IgLC) genes through SHM and alter their effec-
tor/homing capacity through class-switch recombination
(CSR) in the IgH constant region (1). The majority
(
 
 
 
90%) of somatic mutations in Ig genes are point muta-
tions, the rest are small deletions and duplications. Tetra-
mers with a RGYW and its inverse complement WRCY
(R is A or G, Y is C or T, and W is A or T) are intrinsic
mutational hot spots where 
 
 
 
50–60% of all mutations are
found (2). Mutations are restricted to the hypermutation
domain a region of 
 
 
 
2 kb downstream of the Ig promoter
encompassing the rearranged V(D)J gene segment and, in
the case of the VJ rearranged 
 
 
 
 LC locus, reaches into the
5
 
 
 
 end of the constant region (3). The preferential targeting
of mutations to this domain points to the existence of cis-
acting element(s) capable of targeting the ‘hypermutator’ to
V gene regions. The Ig promoter, the Ig enhancers, but not
the rearranged V(D)J region itself (4) have been identified
as critical cis acting elements in controling SHM (2, 5, 6).
The mutation load of rearranged Ig genes correlates with
transcription, and can be tuned experimentally by tran-
scription (7, 8).
Activation-induced cytidine deaminase (AID) has been
identified as a key protein in controlling SHM and CSR
(9–11), two central events of late B cell development. In
humans, mutations in AID are causative for the develop-
ment of the autosomal recessive form of the hyper-IgM
syndrome 2 (HIGM2) (11). AID, a 24-kD protein, is simi-
lar to the cytidine deaminase Apobec-1 and both are en-
coded in close proximity on human chromosome 12p13.
Apobec-1 serves as the catalytic subunit of the apolipopro-
tein B (apoB) mRNA-editing complex and associates with
the Apobec-1 Complementation Factor (ACF), a 65-kD
protein that contains three RNA-binding motifs. Within
this complex, Apobec-1 deaminates specifically the C
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the apo-B mRNA into a U
 
6666
 
, converting codon 2153
from a glutamine (CAA) into a premature stop codon
(UAA) (12, 13). AID might function like other members
belonging to this gene family as a catalytic subunit of a
RNA editing holoenzyme, editing for example the mRNA
of a protein involved in either nicking, repairing or synthe-
sizing DNA. Alternatively, as AID can deaminate deoxycy-
tidine (9), AID itself might be part of the ‘hypermutator’
and ‘class-switcher’ to function more directly as a nick or
single nucleotide gap-inducing enzyme. Together with
ACF-like factor(s) AID might specifically deaminate dC in
secondary structures of transcribed DNA. Hydrolysis of dC
to dU are frequent spontaneous lesions that are efficiently
repaired by base excision repair (BER) and if occurring
on both strands can lead to double-strand breaks (DSBs;
reference 14).
Indirect and direct evidence for DNA DSBs as interme-
diates in hypermutating Ig genes has accumulated (15–19).
The generation of DSBs is favored by transcription and like
for somatic hot spot mutations these DSBs occur preferen-
tially at RGYW motifs within the hypermutation domain
(16, 20). These DSBs likely occur as a result of two single
strand DNA breaks which are introduced by an unknown
nuclease and cause staggered DSBs. Based on these data,
models related to the one of Brenner and Milstein (21)
have been proposed, in which mutations are introduced by
an error prone fill-in reaction of staggered DNA breaks. In
accordance to these models the DNA polymerases 
 
 
 
 and 
 
 
 
,
both capable of translesion synthesis, i.e., bypassing and
continuing DNA synthesis in the presence of a lesion, have
recently been linked to SHM (22–24).
 
Materials and Methods
 
Mice.
 
The generation and genotyping of AID- and Ig
 
 
 
-defi-
cient mice have been described elsewhere (10, 25).
 
Immunization.
 
Ig
 
  
 
knockout mice were immunized with 0.2
ml of a 10% sheep red blood cells solution in PBS (16). AID
knockout mice were immunized with NP-CG. For the immuni-
zation with NP-CG, NP(28)-CGG
 
®
 
 (Biosearch Technologies,
Inc.) is resuspended at 1 mg/ml in PBS, an equal volume of Alu-
Gel-S
 
® 
 
(Serva) is added, mixed, incubated overnight at 4
 
 
 
C, and
0.2 ml of this suspension (100 
 
 
 
g NP(28)-CGG) is injected intra-
peritoneally. For the analysis of DNA DSBs mice were killed 7 d
after immunization, for the analysis of SHM mice were killed 10 d
after immunization.
 
Cell Sorting and DNA Isolation.
 
Sorting of GC and non-GC
B cells was done using a combination of magnet activated cell
sorting (MACS
 
®
 
) (Miltenyi Biotec) and fluorescence activated
cell sorting (FACS
 
®
 
) using a FACStar™ (Becton Dickinson). The
isolation of high molecular weight DNA from these fractions has
been described elsewhere (16). Sorting of V
 
 
 
1&2-expressing GC
and non-GC B cell subsets was achieved with a V
 
 
 
1&2-spe-
cific mAb.
 
Analysis of SHM in Germline V
 
 
 
1 Gene Segments.
 
For the
amplification of germline V
 
 
 
1 gene segments a seminested PCR
assay was applied using the reverse V
 
 
 
1 intron primer in combi-
nation with the V
 
 
 
1&2 external primer for the first round and
the V
 
 
 
1&2 internal primer for the second round of PCR amplifi-
 
cation. The PCR amplification was performed as described previ-
ously (26).
 
Amplification, Cloning, and Sequencing of Splinkerette-ligated V
 
 
 
Genes.
 
The ligation of the splinkerettes has been described else-
where (26). The quantity of the DNA used is based on a defined
number of sorted cells. Based on previous experiments and as de-
termined by semiquantitative PCR reactions with Ku70 specific
primers (see below) this method of DNA quantification is repro-
ducible. Specific amplification of adaptor-ligated V
 
 
 
1&2 genes
from genomic DNA was achieved by using a nested PCR strat-
egy. In the first round the external splinkerette primer was used
in combination with the external V
 
 
 
 primer. For the second
round of amplification the internal splinkerette primer was used
in combination with the internal V
 
 
 
 primer. To detect any V
 
 
 
/
adaptor hybrids, we used the same PCR conditions as described
for the amplification of the V
 
 
 
1 genes from single cells (26).
PCR products were resolved on a 2% (wt/vol) agarose gel, visu-
alized with ethidium bromide under UV-light and isolated from
agarose gel slices using a QiaQuick
 
®
 
 matrix (QIAGEN). After
isolation the PCR products were cloned into the TOPO pCRII
 
®
 
vector from the TOPO TA Cloning
 
®
 
 kit (Invitrogen) and se-
quenced using the DyeDeoxy Terminator Cycle Sequencing
 
®
 
 kit
(Applied Biosystems).
 
Oligonucleotides.
 
V
 
 
 
1&2 external primer: 5
 
 
 
-GGGTATG-
CAACAATGCGCATCTTGTC-3
 
 
 
; V
 
 
 
1&2 internal primer:
5
 
 
 
-GCGAAGAGAAGCTTGTGACTCAGGAATCTGCA-3
 
 
 
;
and V
 
 
 
1 intron primer: 5
 
 
 
-AATGATTCTATGTTCTGCCA-
AGTC-3
 
 
 
. External splinkerette primer: 5
 
 
 
-CGAAGAGTAAC-
CGTTGCTAGGAGAGACC-3
 
 
 
. Internal splinkerette primer:
5
 
 
 
-GTGGCTGAATGAGACTGGTGTCGAC-3
 
 
 
. Splinkerette
oligomers: 5
 
 
 
-CGAAGAGTAACCGTTGCTAGGAGAGACC-
GTGGCTGAATGAGACTGGTGTCGACACTAGTGG-3
 
 
 
 (long
strand, 61-mer); 5
 
 
 
-CCACTAGTGTCGACACCAGTCTCTA-
ATTTTTTTTTTCAAAAAAA-3
 
 
 
 (short strand, 44-mer); 5
 
 
 
-
ACACGGCTTCCTTAATGTGA-3
 
 
 
 (KU70 forward primer);
and 5
 
 
 
-GGCTGGCTTTAGCACTGTCA (KU70 reverse primer).
 
Online Supplemental Material.
 
The exact location of all break
sites shown in Figs. 2 and 4 are indicated in five separate pdf files.
Online supplemental material can be found at http://www.
jem.org/cgi/content/full/jem.20011749/DC1.
 
Results and Discussion
 
To determine whether AID functions as a catalytic sub-
unit of an RNA-editing holoenzyme or more directly up-
stream of DSBs as a nick-inducing enzyme, i.e., by deami-
nating dCs within the hypermutation domain (9, 27, 28) a
ligation-mediated (LM)-PCR protocol (16) was applied.
This protocol allows us to identify ex vivo the frequency,
distribution and sequence preference of DSBs in Ig
 
 
 
 LC
genes of hypermutating B cells. The Ig
 
 
 
 locus arose by
gene duplication (Fig. 1). Compared with Ig
 
 
 
, Ig
 
 
 
-LC–
expressing B cells normally represent 
 
 
 
5% of all B cells (25).
Therefore, the occurrence of DSBs in the Ig
 
 
 
 locus is first
Figure 1. Genomic organization of the mouse Ig  locus (see text). 
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analyzed in GC (CD19
 
 
 
, PNA
 
high
 
) and non-GC (CD19
 
 
 
,
PNA
 
low
 
) B cells of Ig
 
 
 
-deficient mice where only 
 
 
 
LC-
expressing B cells develop (25). High molecular weight DNA
was carefully isolated from these B cell fractions and ali-
quots corresponding to a defined number of sorted B cells
were ligated to blunt-ended DNA adapters. The V
 
 
 
/adap-
tor hybrids were PCR amplified in two rounds. The two
primer sets used hybridize specifically within the 5
 
 
 
 region
of V
 
 
 
1&2 genes and to the complement of the long strand
of the splinkerette, respectively (16, 28). If DSBs exist in
the V
 
 
 
1&2 region of hypermutating B cells, the PCR
products should occur in a size range of the hypermutation
domain. As previously demonstrated for the targeted
V
 
H
 
B1–8 gene (16) distinct PCR products were found in
hypermutation competent GC B cells and only infre-
quently in small, non-GC B cells (Fig. 2 A and B). South-
ern blot analysis with a radiolabeled V
 
 
 
1 probe and
sequencing revealed the specificity of nearly all PCR prod-
ucts (data not shown). After sequencing the PCR products,
the identity, location, and site preference of DSBs in the
Ig
 
 
 
 locus were determined. DSBs are found in a region of
100–2,000 basepairs downstream of rearranged V
 
 
 
1&2
genes and interestingly also in nonrearranged, i.e., germline
configured V
 
 
 
1&2 segments of the 
 
 
 
 LC locus (Fig. 2 B).
Considering the 19 tetramers with a RGYW/WRCY con-
sensus in the V
 
 
 
1&2 segments, 38% of randomly distrib-
uted DSBs are expected to occur at these sites. However,
57% (43/76) of all DSBs locate at these sites, indicating a
preference of DSBs to occur in RGYW/WRCY motifs. A
hot spot of DSBs composed of repetitive Gs locates 5
 
 
 
 of
the complementary determining region 3 (CDR3) and is
also a hot spot for mutations in V
 
 
 
1 as was also shown for
IgH genes (19, 26, 29).
The presence of a J
 
 
 
 element or a recognition signal se-
quence, which is used for the rearrangement of the V to J
element in the Ig LC loci, at the 3
 
 
 
 end of V
 
 
 
 segments
distinguishes between DSBs in rearranged and germline
V
 
 
 
 genes, respectively. Excluding the DSBs within V
 
 
 
segments, the relative frequency of DSBs in rearranged
versus germline Ig
 
 
 
 gene segments can be determined. Of
the remaining 29 DSBs, 48% (14/29) of the DSBs were
found downstream of rearranged and 52% (15/29) down-
stream of germline V
 
 
 
1 gene segments. As transcription
favors the generation of DSBs (16, 17) and each of the two
autonomous Ig
 
 
 
 enhancers, E
 
 
 
2–4 and E
 
 
 
3–1 can inde-
pendently activate transcription of rearranged and nonre-
arranged V
 
 
 
 genes (30), a high frequency of DSBs in germ-
line V
 
  gene segments is expected. Only 14% (2/14) of
the DSBs in V 2 gene segments are found downstream of
rearranged and 86% (12/14) downstream of germline V 2
gene segments. This finding likely relates to the fact that
VJ rearrangements at the Ig  locus of B cell precursors
preferentially (90%) make use of V 1 segments, leaving
most V 2 alleles in germline configuration (25). In this
context it should be mentioned, that according to the en-
hancer flip-flop model (30) a single enhancer suffices to
activate sequentially several promoters. Therefore, DSBs
in germline VH or V  gene segments are also expected to
be introduced, albeit taking the cooperation between the
intronic and 3  enhancers at the IgHC and Ig  LC locus
and the distance to upstream V gene promoters into ac-
count at lower frequency.
To finally determine whether AID functions upstream or
downstream of DSBs, V 1  expressing GC (CD19 ,
V 1 , PNAhigh) and non-GC B cells (CD19 , V 1 ,
PNAlow) were sorted 7 d after the immunization with 100
 g NP-CG from the spleen of AID-deficient and AID-
proficient mice (Fig. 3). Genomic DNA isolated from a de-
fined number of sorted B cells was used to determine the
frequency and distribution of DSBs in V 1&2 genes. The
DNA content of the different DNA samples used was equal
as verified by semiquantitative PCR (data not shown). The
adaptor-ligated DNA samples were titrated and the V 1&2
specific 5  break sites amplified. The titration step allows a
better estimation of the DSB frequency. Apparently, AID-
deficiency does not affect significantly the frequency (num-
Figure 2. DSBs in the Ig  locus of GC B cells from Ig  knockout mice. (A) Detection of DSBs. LM-PCR products of the 5  break sites from 10,000
(1), 5,000 (2), 2,500 (3), 1,250 (4), and 625 (5) cell-equivalents of GC B cells (CD19 , PI , PNAhigh) and non-GC B cells (CD19 , PI , PNAlow) from
Ig  knockout mice. Numbers at the side indicate the location of the DNA size markers (basepairs). (B) DSBs in rearranged (re) and germline (gl) V  gene
segments of hypermutating Ig -deficient GC B cells. The distribution and location of the DSBs found are depicted as arrows. Vertically aligned arrows
indicate DSBs obtained from independent LM-PCR reactions. Closed arrows indicate DNA-DSBs at an RGYW motif, open arrows indicate DNA-
DSBs outside an RGYW motif. P, location of the V  internal primer. 1, 2, 3, location of the complementary determining regions (CDR1, 2, and 3, re-
spectively). Asterisks above arrows indicate DSBs in V 1J 3 rearranged   LC genes. Triangles indicate the recognition signal sequence.1190 DNA Double-Strand Breaks Alone Are Not Sufficient for Hypermutation
ber of PCR products) and distribution of DSBs (size range
of PCR products) along the rearranged and germline
V 1&2 genes of GC B cells (Fig. 4 A). To determine,
whether these breaks differ qualitatively, the PCR products
were cloned and sequenced. Considering the 19 tetramers
with a RGYW consensus in V 1&2 segments, 38% of ran-
domly distributed DSBs are expected to occur at these sites.
However, 56% (15/27) of all DSB found in AID-deficient
GC B cells locate at a RGYW consensus motif. As summa-
rized in Fig. 4 B, the generation, distribution as well as the
preference of DSBs to occur in RGYW motifs appear not
to be controlled by AID. If rearranged and germline-con-
figured V  genes are equal substrates of an unknown nu-
clease, are they also equally targeted by the SHM system?
To (re)-address this question in our system the mutation
frequencies of rearranged and nonrearranged V 1 genes
were determined by amplifying and sequencing these re-
gions from single class-switched V 1 , CD19 , Ig - -
memory B cells isolated from the spleen of C57Bl/6 mice
(26). Despite the fact that DSBs are found at an equal fre-
quency in rearranged and germline V 1 genes, the fre-
quency of mutations differs. While 57% (42/74) of rear-
ranged V 1 genes were mutated at a frequency of 0.61%
(144 mutations in 23,680 basepairs sequenced), only 21%
(7/34) of germline V 1 genes sequenced were mutated at a
frequency of 0.11% (12 mutations in 10,880 base pairs se-
quenced). Taking into account that SHM has been active
in 57% of the cells, the actual mutation frequency is 1.07%
for rearranged and 0.19% for germline V 1 genes. In line
with previous studies,  60% of class switched V 1 ,
CD19 , Ig - - memory B cells have a mutated, rear-
ranged V 1 gene (8, 26) and mutations in germline config-
ured V  segments occur, but at a significantly lower fre-
quency (3, 31). Therefore, although DSBs are introduced
at similar frequencies in germline and rearranged V 1&2
genes, SHM is preferentially targeted to the rearranged
V 1&2 genes, indicating that a DSB itself does not suffice
for optimal targeting of the hypermutation machinery. We
propose that DSBs usually are efficiently repaired in a non-
mutagenic manner and in general do not lead to cell death.
The frequency of SHM in AID proficient and AID-defi-
cient GC (PNAhigh, V 1 , CD19 ) and non-GC (PNAlow,
V 1 , CD19 ) B cells was determined by single cell PCR
of rearranged V 1 genes (26). While the mutation fre-
quency of rearranged V 1 genes in AID-proficient GC B
cells is 0.64%, the frequency of mutations in AID-deficient
GC B cells is similar to the Taq-error frequency deter-
mined for our assay, 0.018 and 0.025%, respectively.
In conclusion, SHM is preferentially targeted to rear-
ranged V  gene segments. As the generation of DSBs is de-
pendent on transcription, or at least on the initiation of
transcription (16, 17), the occurrence of DSBs in germline
and rearranged V  genes at a similar frequency likely relates
to the presence of two independent   enhancers. Although
DSBs are introduced at a similar frequency in VJ rearranged
and nonrearranged V 1 genes, the data clearly show that
most of the DSBs are AID independent. Therefore, we can
formally raise three possibilities: (i) none of the DSBs are
involved in SHM; (ii) only a small fraction of DSBs are in-
volved in SHM; and (iii) AID functions downstream of
DSBs. The first possibility is in view of previous studies un-
likely because several independent groups have provided
direct and indirect evidence for DSBs being associated with
SHM (for a review, see reference 28). Like the first possi-
bility, the second possibility places AID upstream of DSBs.
This suggests that the DSBs in AID-deficient GC B cells
are not related to SHM, however leaving the possibility
Figure 3. Splenic B cells were positively enriched by magnet activated
cell sorting (MACS®) using CD19-specific beads. AID-deficient B cells
are shown as an example. Hereafter cells were stained with a FITC-con-
jugated CD19 specific mAb (clone 1D3), a PE-conjugated V 1/2-spe-
cific mAb (clone LS136), and biotinylated peanut agglutinin (PNA). Bio-
tinylated PNA was revealed indirectly with streptavidin-allophycocyanin
(SA-APC; Molecular Probes). GC-B cells (PNAhigh) in which SHM is
known to be ongoing have compared with non-GC B cells (PNAlow) more
binding sites for PNA. Dead cells were excluded by propidium iodine
staining (PI ). Viable (PI ) B cells (CD19 ) were sorted into a PNAlow,
V 1&2 , and a PNAhigh, V 1&2  fraction (MoFlo® Cytomation).
Figure 4. DSBs in the Ig  locus of AID-deficient GC B cells and non-
GC B cells. (A) AID does not control the generation of DSBs in hyper-
mutating Ig genes. LM-PCR products derived from the amplification of
the 5  break sites in V 1&2 gene segments from 10,000 (1), 5,000 (2),
2,500 (3), 1,250 (4), and 625 (5) cell equivalents of GC B cells (V  ,
CD19 , PI , PNAhigh) from AID /  and AID /  mice as well as non-
GC B cells (V  , CD19 , PI , PNAlow) from AID-deficient mice were
separated on a 2% (wt/vol) TAE agarose gel and visualized with ethidium
bromide under UV-light. The DNA size markers are indicated in base-
pairs. As revealed by Southern blotting and sequencing most PCR prod-
ucts are V 1&2 specific. (B) DSBs in rearranged and nonrearranged V 
genes of GC B cells from AID deficient mice (see text). For abbreviations,
see legend to Fig. 2.1191 Bross et al. Brief Definitive Report
that a minority of DSBs found in AID proficient GC B
cells are indeed related to the process of SHM, either as an
intermediate or as a byproduct. The last possibility that
AID functions downstream of the DSBs is also possible but
appears to be unlikely because of a recent publication by
Petersen et al. (32) indicating that AID is required to ini-
tiate the focus formation of Nijmegen breakage syndrome
protein and phophorylated H2A histone family member X
protein at sites of CSR. Present studies aim on the identifi-
cation and characterization of the RNA substrate, RNA-
binding protein within the putative RNA-editing com-
plex, the identification of the nuclease, and the DNA repair
pathway involved.
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